Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi

Rokko Holdings Limited

This is a 'small float' company with only 30m shares (28m placement and 2m public). It will be extremely difficult to get the shares from the public offering. Due to the small float, it is likely to be a stag on the first day but may dribble lower once investors forget about this counter. In addition, it is also in the tech sector which in my view, is not very 'exciting'. Although it is likely to be a 'stag' for IPO punters, i think investors can give this counter a miss for the following reasons:

(1) Difficult to get at the IPO

(2) Unattractive sector as it is very dependent on the semiconductor industry which is very volatile and cyclical.

(3) Fair value is only a slight premium to the IPO price.

Comments